Ablation Products for Atrial Fibrillation Healthcare Professionals
The Arctic Front Advance™ Cryoballoon is the leading cryoballoon approved in the U.S. to treat drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF). It has a low complication risk and a proven efficacy in treating PAF.1
The Achieve™ and Achieve Advance™ Mapping Catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front Advance™ Cardiac Cryoablation Catheter, the FlexCath™ Advance Steerable Sheath and the CryoConsole.
The Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the Cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.
The CryoConsole houses the components and software needed to perform Cryoablation procedures with the Arctic Front Advance Cardiac Cryoablation Catheter or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.
The FlexCath Advance™ Steerable Sheath is part of the Arctic Front Advance™ Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front Advance™ Cardiac Cryoablation Catheter. It can also be used with the Freezor™ MAX Cardiac Cryoablation Catheter.
Product names on this page are trademarks or registered trademarks of Medtronic.
Okumura K, et al. Safety and Efficacy of Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Japan- Results From the Japanese Prospective Post-Market Surveillance Study. Circ J. 2016 Jul 25;80(8):1744-9.